Brief: Crescita - Cash And Cash Equivalents Balance Of $13,005 As At Sept 30
07/11/2019 13:21
Nov 7 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS- GENERATED $1,316 IN CASH DURING
QUARTER,
RESULTING IN AN ENDING CASH AND CASH EQUIVALENTS BALANCE OF
$13,005 AS AT SEPT 30
Source text for Eikon: ID:nCNWTzBTDa
Further company coverage: CTX.TO
((Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium